Salvage High-dose-rate Interstitial Brachytherapy for Pelvic Recurrent Cervical Carcinoma After Hysterectomy

被引：5
|
作者：
Murakami, Naoya [1 ]
Kato, Tomoyasu [2 ]
Miyamoto, Yuichiro [3 ]
Nakamura, Satoshi [1 ]
Wakita, Akihisa [1 ]
Okamoto, Hiroyuki [1 ]
Tsuchida, Keisuke [1 ]
Kashihara, Tairo [1 ]
Kobayashi, Kazuma [1 ]
Harada, Ken [1 ]
Kitaguchi, Mayuka [1 ]
Sekii, Shuhei [1 ]
Takahashi, Kana [1 ]
Umezawa, Rei [1 ]
Inaba, Koji [1 ]
Ito, Yoshinori [1 ]
Igaki, Hiroshi [1 ]
Itami, Jun [1 ]
机构：
[1] Natl Canc Ctr, Dept Radiat Oncol, 5-1-1 Tsukiji, Tokyo 1040045, Japan
[2] Natl Canc Ctr, Dept Gynecol Oncol, 5-1-1 Tsukiji, Tokyo 1040045, Japan
[3] Saitama Canc Ctr, Dept Gynecol, Saitama, Japan
来源：
ANTICANCER RESEARCH | 2016年 / 36卷 / 05期
关键词：
Salvage interstitial brachytherapy; high-dose-rate interstitial brachytherapy; uterine cervical cancer; post hysterectomy relapse; MODULATED RADIATION-THERAPY; GYNECOLOGIC-ONCOLOGY-GROUP; CLINICAL TARGET VOLUME; RADICAL HYSTERECTOMY; COMPUTED-TOMOGRAPHY; CANCER; RADIOTHERAPY; STAGE; MALIGNANCIES; EXENTERATION;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Background: The aim of this study was to report the clinical results of salvage high-dose-rate interstitial brachytherapy (HDR-ISBT) for patients with cervical cancer with pelvic recurrence after hysterectomy. Patients and Methods: When there was no indication for total pelvic extenteration (TPE) and the tumor depth was more than 5 mm of invasion in the paracolpium, salvage HDR-ISBT was applied. Results: A total of 26 patients were included in this study. The median number of fractions and dose per fraction of HDR-ISBT were 5 (range=3-20 fractions) and 6 Gy (range=2.5-6 Gy), respectively. Three-year local control, progression-free survival, and overall survival were 51.1%, 34.4% and 57.1%, respectively. Combination of external-beam radiation therapy, clinical target volume D90 greater than 65 Gy, and dose per fraction greater than 5 Gy were associated with favorable local control. Conclusion: For patients with recurrent cervical cancer post hysterectomy who are not candidates for TPE, salvage HDR-ISBT is a possible curative treatment modality.
引用
收藏
页码：2413 / 2421
页数：9
相关论文
共 50 条
  • [31] Salvage high-dose-rate (HDR) brachytherapy for recurrent head-and-neck cancer
    Hepel, JT
    Syed, AMN
    Puthawala, A
    Sharma, A
    Frankel, P
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 62 (05): : 1444 - 1450
  • [32] Salvage high-dose-rate brachytherapy for previously irradiated locally recurrent prostate cancer
    Galdeano-Rubio, M.
    Guiterrez-Miguielez, C.
    Najjari-Jamal, D.
    Modolell-Farre, I.
    Ferrer-Gonzalez, F.
    Boladeras-Inglada, A.
    Gracia-Lucio, R.
    Suarez-Novo, J. F.
    Pera-Fabregas, J.
    Guedea-Edo, F.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S129 - S130
  • [33] Image-Guided Interstitial High-Dose-Rate Brachytherapy in Hepatocellular Carcinoma
    Mohnike, Konrad
    Wieners, Gero
    Pech, Maciej
    Seidensticker, Max
    Ruehl, Ricarda
    Lopez-Haenninen, Enrique
    Ricke, Jens
    DIGESTIVE DISEASES, 2009, 27 (02) : 170 - 174
  • [34] High-dose-rate interstitial brachytherapy for gynecologic malignancies
    Beriwal, Sushil
    Bhatnagar, Ajay
    Heron, Dwight E.
    Selvaraj, Raj
    Mogus, Robert
    Kim, Hayeon
    Gerszten, Kristina
    Kelley, Joseph
    Edwards, Robert P.
    BRACHYTHERAPY, 2006, 5 (04) : 218 - 222
  • [35] Efficacy of high-dose-rate interstitial brachytherapy in patients with oral tongue carcinoma
    Luis Guinot, Jose
    Santos, Miguel
    Isabel Tortajada, Maria
    Carrascosa, Maria
    Estelles, Enrique
    Bosco Vendrell, Juan
    Muelas, Rodrigo
    Luisa Chust, Maria
    Luis Mengual, Jose
    Arribas, Leoncio
    BRACHYTHERAPY, 2010, 9 (03) : 227 - 234
  • [36] Interstitial high-dose-rate brachytherapy in eyelid cancer
    Mareco, Virginia
    Bujor, Laurentiu
    Abrunhosa-Branquinho, Andre N.
    Ferreira, Miguel Reis
    Ribeiro, Tiago
    Vasconcelos, Ana Luisa
    Ferreira, Cidalina Reis
    Jorge, Marilia
    BRACHYTHERAPY, 2015, 14 (04) : 554 - 564
  • [37] EVALUATION OF RECTAL DOSE DURING HIGH-DOSE-RATE INTRACAVITARY BRACHYTHERAPY FOR CERVICAL CARCINOMA
    Sha, Rajib Lochan
    Reddy, Palreddy Yadagiri
    Rao, Ramakrishna
    Muralidhar, Kanaparthy R.
    Kudchadker, Rajat J.
    MEDICAL DOSIMETRY, 2011, 36 (04) : 377 - 382
  • [38] Efficacy and toxicity following salvage high-dose-rate brachytherapy for locally recurrent prostate cancer after radiotherapy
    Kissel, Manon
    Pounou, Arthur
    Ka, Kanta
    Alexis, Anthony
    Irani, Jacques
    Jereczek-Fossa, Barbara Alicja
    Terlizzi, Mario
    Bossi, Alberto
    Blanchard, Pierre
    BRACHYTHERAPY, 2022, 21 (04) : 424 - 434
  • [39] Interstitial high-dose-rate brachytherapy combined with cervical dissection on head and neck cancer
    Pellizzon, ACA
    Novaes, PERD
    Maia, MAC
    Ferrigno, R
    Fogarolli, R
    Salvajoli, JV
    Kowalski, LP
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2005, 27 (12): : 1035 - 1041
  • [40] TREATMENT OF RECURRENT BRONCHIAL CARCINOMA: THE ROLE OF HIGH-DOSE-RATE ENDOLUMINAL BRACHYTHERAPY
    Hauswald, Henrik
    Stoiber, Eva
    Rochet, Nathalie
    Lindel, Katja
    Grehn, Christian
    Becker, Heinrich D.
    Debus, Juergen
    Harms, Wolfgang
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 77 (02): : 373 - 377
12345